A few honest points: Alcohol and GLP-1 medications can stack their stomach effects
Clinical trials consistently show tirzepatide produces about 5% more body weight loss than semaglutide, likely due to this dual mechanism
It can lead to a decrease in blood pressure, improved insulin sensitivity, and a reduction in markers of inflammation
The timing of starting a new medication and the onset of new symptoms can create an apparent association that may not reflect true causation
This slowdown keeps you feeling full for longer, which further reduces your food intake
Reversal of FDA Guidance Remarkably, just two days after this announcement, the FDA reversed its decision, allowing compounded pharmacies to continue making tirzepatide